QID 241231

Date Published: 2023-03-01

QID 241231: Red Hat Update for OpenStack Platform 17.0 (RHSA-2023:1015)

Openstack compute (codename nova) is open source software designed.to provision and manage large networks of virtual machines,creating a.redundant and scalable cloud computing platform.
It gives you the software,.control panels, and apis required to orchestrate a cloud, including running.instances, managing networks, and controlling access through users and.projects.
Openstack compute strives to be both hardware and hypervisor.agnostic, currently supporting a variety of standard hardware.configurations and seven major hypervisors...Security Fix(es):

    arbitrary file access through custom vmdk flat descriptor.
Affected Products:
    Red Hat openstack 17 x86_64.
.

Note: The preceding description block is extracted directly from the security advisory. Using automation, we have attempted to clean and format it as much as possible without introducing additional issues.

Successful exploitation of this vulnerability could lead to a security breach or could affect integrity, availability, and confidentiality.

  • CVSS V3 rated as Medium - 5.7 severity.
  • CVSS V2 rated as Medium - 5.4 severity.
    • Solution
    Refer to Red Hat security advisory RHSA-2023:1015 for updates and patch information.
    Vendor References

    CVEs related to QID 241231

    CVE-2022-47951 |
    Software Advisories
    Advisory ID Software Component Link
    RHSA-2023:1015 Red Hat Enterprise Linux URL Logo access.redhat.com/errata/RHSA-2023:1015
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].